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Gabor Forgacs,6,7 Jürgen Groll,8 Qing Li,9 Jos Malda,10,11 Vladimir A. Mironov,12,13 Carlos Mota,1
Makoto Nakamura,14 Wenmiao Shu,15 Shoji Takeuchi,16 Tim B.F. Woodfield,17 Tao Xu,18
James J. Yoo,19 and Giovanni Vozzi4
Biofabrication holds the potential to generate constructs that more closely
recapitulate the complexity and heterogeneity of tissues and organs than do
currently available regenerative medicine therapies. Such constructs can be
applied for tissue regeneration or as in vitro 3D models. Biofabrication is
maturing and growing, and scientists with different backgrounds are joining
this field, underscoring the need for unity regarding the use of terminology. We
therefore believe that there is a compelling need to clarify the relationship
between the different concepts, technologies, and descriptions of biofabrica-
tion that are often used interchangeably or inconsistently in the current liter-
ature. Our objective is to provide a guide to the terminology for different
technologies in the field which may serve as a reference for the biofabrication
community.
What Do We Mean by Biofabrication?
By combining the principles of engineering, biology, and material science, biofabrication holds
great promise to change the toolbox for many biotechnological disciplines. Recently, in the
context of tissue engineering and regenerative medicine applications, the definition of biofab-
rication as a research field was updated as ‘the automated generation of biologically functional
products with structural organization from living cells, bioactive molecules, biomaterials (see
Glossary), cell aggregates such as micro-tissues, or hybrid cell-material constructs, through
bioprinting or bioassembly and subsequent tissue maturation processes’ [1]. This definition
includes the fabrication of scaffolds with hierarchical structural properties or smart-surface
properties within the realm of bioprinting. It was reasoned that the design of such features
would be indispensable to obtain structurally functional biological substitutes. This work pro-
vided an overview of the historical evolution and broader meaning of the term, and also specified
the research field with a focus on applications in tissue engineering and regenerative medicine,
and proposed bioprinting and bioassembly as the two major approaches to biofabrication.
Despite this definition and positioning of the field, as well as recent reviews that nicely provide a
common framework to the additive manufacturing field at large [2–5], the terminology commonly
used, especially in recent literature, is not clearly defined and lacks consensus. This absence of
an agreed and accepted terminology can, and partially already does, lead to uncertainty or
confusion in the description of new approaches and possible misunderstanding as to where a
new report fits in relation to previous reports. This could impede the development of the field by
making it difficult to correctly map progress in the science and technology of biofabrication.
We intend here to follow-up from our previous review updating the definition of biofabrication for
tissue engineering and regenerative medicine applications [1]. We aim to set an overarching
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Biofabrication holds great potential in
the fields of regenerative medicine and
physiological 3D in vitro models by
allowing the manufacture of complex
tissue constructs with a higher degree
of biomimicry to native tissues than do
current biomedical solutions.
As the number of biofabrication tech-
nologies being developed continues to
expand, it is of paramount importance
to adopt a concerted terminology fra-
mework and avoid generalizations.
The ratio between the spatial resolu-
tion and the timescale of manufacture
could be considered as a reliable mea-
sure to aid in the selection of an appro-
priate biofabrication technology for a
desired application.
1MERLN Institute for Technology-
Inspired Regenerative Medicine,
Department of Complex Tissue
Regeneration, Maastricht
University, Maastricht, The
Netherlands
2Department of Metallurgical,
Materials and Biomedical Engineering,
The University of Texas at El Paso, El
Paso, TX, USA
3Department of Bioengineering,
University of Pennsylvania,
Philadelphia, PA, USA
4Research Center ‘E. Piaggio’ and
Dipartimento di Ingegneria
dell’Informazione, University of Pisa,
Pisa, Italy
5School of Materials, University of
Manchester, Manchester, M13 9PL,
UK
6Department of Physics, Biology and
Biomedical Engineering, University of
384 Trends in Biotechnology, April 2018, Vol. 36, No. 4 https://doi.org/10.1016/j.tibtech.2017.10.015
© 2017 Elsevier Ltd. All rights reserved.
Missouri, Columbia, MO, USA
7Modern Meadow Inc., Brooklyn, NY,
USA
8Department of Functional Materials in
Medicine and Dentistry, University of
Würzburg, Würzburg, Germany
9School of Aerospace, Mechanical
and Mechatronic Engineering,
University of Sydney, Sydney,
Australia
10Department of Orthopedics,
University Medical Center Utrecht,
Utrecht, The Netherlands
11Department of Equine Sciences,
Faculty of Veterinary Medicine,
Utrecht University, Utrecht, The
Netherlands
123D Bioprinting Solutions, Moscow,
Russian Federation
13Sechenov Medical University,
Moscow, Russia
14Graduate School of Science and
Engineering for Research, University
of Toyama, Toyama, Japan
15Department of Biomedical
Engineering, University of Strathclyde,
Glasgow, UK
16Institute of Industrial Science,
University of Tokyo, Tokyo, Japan
17Department of Orthopedic Surgery
and Centre for Bioengineering and
Nanomedicine, University of Otago,
Christchurch, New Zealand
18Department of Mechanical
Engineering, Tsinghua University,
Beijing, China
19Wake Forest Institute for
Regenerative Medicine, Wake Forest
School of Medicine, Winston-Salem,
NC, USA
@Twitters: @MoroniGroup,
@BioFabUnipi
*Correspondence:
l.moroni@maastrichtuniveristy.nl
(L. Moroni).
terminology framework by clarifying the technologies used within biofabrication strategies, as
well as rationalizing appropriate terminologies, as an integral basis for communication in all the
different application fields of biofabrication. We therefore feel that a brief review of classical and
novel biofabrication approaches, with the aim to point out the differences among them and the
limitations that must still be overcome, is timely. A Glossary of the main different terminologies
clarified in this article is also provided in this article. We also point out potential future research
directions where we believe biofabrication may have a major impact, with the objective to
collaborate with industry to bring biofabrication strategies to the clinic in a more efficient and
consensual manner, and to collectively overcome future regulatory and ethical challenges.
Technologies Used for Biofabrication
As previously indicated, biofabrication strategies employed for tissue engineering and regen-
erative medicine can be identified as either bioprinting or bioassembly. To further classify the
various technologies used for these strategies in terms of efficiency of fabrication, we introduce
the spatial resolution/time for manufacturing (RTM) ratio as a quantitative characterization
of the process underlying a specific technology, considering the ability to produce scaffolds
with fine details in a short time as a measure of merit. The RTM ratio is defined as:
RTM ¼ Spatial resolution
Time for manufacturing
ffi R  P ¼ 1
d
 V
t
(1)
Here, R is the best spatial resolution that can be achieved within the technology, and P is the
delivery rate of the material being printed or assembled. R is expressed as the inverse of the
minimum feature dimension, d: d is measured in m, thus R is measured in 1/m; P is
expressed as the volume, V, of material (measured in m3) delivered per unit of time, t (in
minutes). As a consequence, the physical dimensions of the RTM ratio are square-length/time.
In the biofabrication field, the order of magnitude of R and P are 1/mm and mm3/minute
respectively: hence, the RTM ratio must be expressed in 103 m2/minute for an easier
comparison between different technologies. Note that, for each specific technology, R and
P may vary, depending on the material delivered, as well as on the geometry of the scaffold and
on its placement in the building chamber.
In the following sections, standard operating procedures are considered (such as commonly
used materials, average printing parameters, single or multiple material deposition head) for
building a 1 cm3 cube of material (V = 106 m3), lying on one of its faces. Table 1 lists the
average RTM ratios for the biofabrication technologies that will be considered in the present
work. Figure 1 (Key Figure) gives a graphical representation of the distribution of the various
biofabrication technologies in the parameter space with axes of minimum feature dimension d
and delivery rate P: as explained above R and P may vary for each technology (represented by
circles). In Figure 1 the contour lines of the RTM function are also plotted: technologies along
the same contour line have the same RTM ratio. Generally speaking, the higher the value of the
RTM ratio, the more efficient the process. Most technologies are placed along the diagonal of
the ‘d-P’ parameter space, indicating that higher delivery rates result in lower resolution, and
fabricating fine details is in contrast with fast manufacturing. We briefly here outline the most
common technologies to illustrate and illuminate their differences, advantages, and limitations.
The most commonly used technologies in biofabrication with a major and active role of
biomaterials in the printing process comprise (i) 3D printing; (ii) light-based technologies
such as selective laser sintering (SLS), selective laser ablation, stereolithography (SLA),
and two-photon polymerization (2PP); (iii) fused deposition modeling (FDM)/3D
fiber deposition (3DF)/bioextrusion; (iv) wet-spun automated extrusion systems;
(v) 3D plotting/bioplotting/robotic dispensing/extrusion bioprinting; (vi) ink-jet and
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valve-jet bioprinting; and (vii) electrospinning (Figure 2). Most of these technologies were
originally developed as additive manufacturing technologies for rapid prototyping, but are
included as biofabrication strategies when used for biomedical applications.
3D Printing
With 3D printing, a jet of binder is directed at a powder bed to define a pattern controlled by
computer-aided design/computer-aided manufacturing (CAD/CAM) software. The solvent
binds the powder, thus forming a slice of solid material; subsequently a new layer of powder
is laid down and the process is repeated to build the scaffold layer-by-layer [6,7]. The unbound
powder acts as a support for the object during building, allowing the easy fabrication of re-
entrant and hollow objects. It can be difficult to remove excess unbound grains and remnants of
used solvents/binder. In this respect, it is important to highlight that the term 3D printing should
only refer to this specific additive manufacturing technology. This technology allows the
Glossary
Bioassembly: the fabrication of
hierarchical constructs with a
prescribed 2D or 3D organization
through automated assembly of
preformed cell-containing fabrication
units generated via cell-driven self-
organization or through preparation
of hybrid cell–material building
blocks, typically by applying enabling
technologies, including
microfabricated molds or
microfluidics.
Bio-engineered structures:
biological constructs engineered by
using in a predefined manner cells,
biomaterials, and/or biological factors
alone or in combination with each
other.
Bioink: formulation of material(s) and
biological molecules or cells
processed using bioprinting
technologies.
Biomaterial: a material that is used
as (part of) a medical device or an
advanced therapy medicinal product
to replace, restore, or regenerate a
tissue or organ and its function.
Bioprinting: the use of computer-
aided transfer processes for
patterning and assembly of living and
non-living materials with a prescribed
2D or 3D organization to produce
bio-engineered structures serving in
regenerative medicine,
pharmacokinetics, and basic cell
biology studies. In this context,
additive manufacturing of 3D
scaffolds able to instruct or induce
the cells to develop into a tissue
mimetic or tissue analog structure,
for example, through distinctive cell
interaction, hierarchical induction of
differentiation, or functional evolution
of the manufactured scaffolds falls
within bioprinting.
Cell spheroid: a cluster of cells with
a spherical shape, typically formed
by allowing a cell suspension to
settle into a droplet of media.
Electrospinning: a material
processing technology that uses high
electrical voltage to fabricate fine
fibers from polymer solution or
molten polymer. Fibers are deposited
onto a collector, with a random or
defined alignment.
Fabrication rate: the rate of
fabrication of a scaffold or of a
bioprinted construct using
biofabrication technology. In the RTM
ratio it can be calculated as the time
Table 1. Main features and Limitations of Biofabrication Techniques
Technique RTM ratio
(103 m2/minute)
Minimum
feature width
(mm = 106 m)
Limitations Refs
3DTM Printing Medium (0.1) 300 Presence of polymeric grains and of
excess solvent
[6,7]
Selective laser
sintering
Medium to high (1) <400 Presence of polymeric grains; limited to
non-thermolabile materials
[8–10]
Laser ablation Medium to high (1) <400 Thermolabile materials (cells and
proteins) can be damaged during
scaffold fabrication
[12,15]
Stereolithography Medium (0.5) 30–70 Use of photosensitive polymers and
initiators, which may be toxic
[18,20]
Two-photo
polymerization
Medium (0.05) <1 Use of photosensitive polymers and
initiators, which may be toxic
[21,22]
Digital light
processing
Medium to high (2) 70–100 Use of photosensitive polymers and
initiators, which may be toxic
[19]
Fused deposition
Modeling
Medium to high (1) 200 Limited use with thermolabile materials.
Evident layered structure
[23–25]
PAM and wet-spun
technologies
Medium (0.5) 20 Limited range of material available, and
low vertical dimension processing time
increases with the number of material
heads used
[35,36]
Indirect additive
manufacturing
Low (0.03) 200 Limited mould materials [40–42]
Bioplotting Medium (0.5) 100 Need a self-sustaining gel (bioink) with a
high degree of shear thinning
[46–48]
Ink-jet bioprinting Medium (0.1) 100 Limited range of gels (bioinks) available;
inks must be of low viscosity
[52,117]
Valve-jet bioprinting Medium (0.3) 200 Delivery rate not sufficient for building
clinically relevant constructs
[56,57]
Electrospinning Medium (0.1) <1 Difficult to realize thick scaffolds [58,59]
Laser-assisted
bioassembly
Low (0.04) 30 Difficult to realize thick scaffolds; limited
range of gels available
[78,79]
Spheroid-based
approaches
Low to very
low (<0.001)
300 Long time for fabrication owing to cell
spheroid production and construct
maturation
[71–74]
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to fabricate a 106 m3 (1 cm3) cube,
lying on one of its faces.
Fused deposition modeling/3D
fiber deposition (3DF)/
bioextrusion: additive manufacturing
technologies that can be used for
bioprinting in which a thermoplastic
material, in shape of filament or
pellet, is hot-extruded and deposited
to form a layer of solid material.
Using a layer-by-layer approach a 3D
scaffold or a 3D construct is built.
Indirect additive manufacturing: a
biofabrication approach that uses an
additive manufactured mold in which
a bioink is cast, injected, or
compressed.
Ink-jet and valve-jet bioprinting:
printing systems able to bioprint
constructs in a layer-by-layer manner
by ejecting bioinks in the form of
droplets via the nozzle head. Droplet
ejection is controlled either by piezo-
or thermal actuators (ink-jet), or by
solenoid microvalves (valve-jet).
Laser-assisted bioprinting (LAB):
also known as laser-induced forward
transfer (LIFT), a bioprinting
technique that uses laser pulses to
deposit a bioink from a donor slide
onto a substrate.
Microfluidic technology: a
technology based on geometrically
constrained minute volume transport
in micro-channels. This technology
can also be used to fabricate strands
of hydrogels that are suitable as
building blocks for successive
assembling processes.
Micro-masonry concept:
biofabrication approach in which
microunits of cell-laden hydrogels are
used as regenerative building blocks.
Minimum feature dimension: the
smallest detail that can be fabricated
using a biofabrication technology.
3D plotting/bioplotting/robotic
dispensing/extrusion bioprinting:
bioprinting technologies that
dispense continuous filaments of
hydrogel materials that are extruded
through nozzles using a piston, a
screwing system, or pneumatic
pressure as the driving force.
Pressure-assisted microsyringe
deposition (PAM)/wet-spun
automated extrusion systems:
additive manufacturing technologies
that can be used for bioprinting
based on the extrusion of polymers
dissolved in volatile solvents. The
quick evaporation of the solvent
Key Figure
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fabrication of structures with a lateral resolution controlled by a combination of the powder
particle size and the volume that the solvent penetrates by capillary action. Current commercial
systems have a feature resolution around 300 mm, which is suboptimal if precise control of cell
positioning is required after scaffold fabrication. Its RTM ratio is about 0.1  103 m2/minute,
and is thus at the medium level of manufacturing efficiency.
Light-Based Technologies
SLS uses a laser where the beam of light is selectively directed to a powder bed, generating
local heat and forming patterns of fused material; after its solidification, a new layer of powder is
laid down and the process is repeated to build the scaffold layer-by-layer. A variety of
thermoplastic polymers [8], metals (in this case SLS is called ‘selective laser melting’), ceramics,
or mixtures of polymer-ceramic [9] and polymer-encapsulated ceramic [10] can be used, but
the required high temperatures limit the utility of SLS for biofabrication processes. The source
materials that are normally used require extra processing to obtain these in powder form with
precise and narrow size granulometry. Selective laser ablation works in the opposite way by
ablating a solid material using a very short duration laser pulse [11,12]. If the ablation process is
conducted in all of the three directions, or if laminated porous films are stacked and bonded on
top of each other, a 3D structure can be created. These techniques have proved useful for the
fabrication of improved tissue constructs upon seeding the scaffold with cells [13–15]. These
technologies do not allow the direct incorporation of pharmaceuticals, biomacromolecules
(proteins, growth factors), or cells into the scaffold. Thus, they could be considered as
biofabrication technologies only when the fabricated scaffolds are designed following hierar-
chical or smart principles to influence cell activity and achieve functional biological constructs,
as previously discussed [1]. In these methods the resolution of the printed pattern depends on
the laser spot size, the thermal conductivity, the surface tension, the absorption of the raw
materials, and grain size. Owing to heat conduction, resolution is inevitably larger than the spot
size. The RTM ratio is 1  103 m2/minute for both technologies, which means that these
techniques are fast even if the resolution is comparable to that of other methods.
A promising modification of SLS that can release active compounds (e.g., ribonuclease, an
exceptionally stable enzyme) is surface selective laser sintering (SSLS) [16], which uses an
infrared laser to sinter powder substrates. In this case the radiation is not absorbed by the
polymer particles but by carbon microparticles spread on the surface of the polymer particles.
However, owing to several challenges, such as the use of carbon microparticles without a
proven track record of biocompatibility, the processing of polymers into powder, and the lack of
extensive studies with unstable biologically active compounds, this technology is not yet ready
for the clinic.
SLA, in which light is used to solidify a photosensitive resin, has been typically used to produce
a negative replica that is filled with ceramic or metallic slurries, and is subsequently removed by
sintering at high temperatures [17]. Biocompatible and biodegradable photosensitive polymers
that can be used in SLA to directly fabricate 3D scaffolds are also being developed and
investigated. A few newly developed photosensitive resins are starting to appear in the
biomaterials field for this purpose, and these have also opened the possibility to use a light
allows shape retention of the 2D
pattern deposited by the 3D
micropositioner. With a layer-by-layer
approach a 3D scaffold can be
fabricated.
3D printing: an additive
manufacturing technology that can
be used for bioprinting in which a jet
of binder is directed at a powder-
bed to define a pattern. The solvent
binds to the powder, forming a slice
of solid material; subsequently a new
layer of powder is laid down, and the
process is repeated to build the
scaffold layer-by-layer.
Resolution/time of manufacturing
(RTM) ratio: a measure used to
rank the performance of
biofabrication technologies. The RTM
ratio is defined as the ratio of the
spatial resolution to the time required
for biofabricating a bio-engineered
structure; a larger RTM ratio
represents a more efficient process.
Selective laser ablation: an
additive manufacturing technology
that can be used for bioprinting in
which a solid material is ablated
using a very short time-duration laser
pulse. If the ablation process is
conducted in all the three directions,
or if laminated porous films are
stacked and bonded on top of each
other, a 3D structure can be created.
Selective laser sintering (SLS): an
additive manufacturing technology
that can be used for bioprinting in
which a beam of laser light is
selectively directed to a powder-bed,
generating local heat and forming
patterns of fused material; after its
solidification, a new layer of powder
is laid down and the process is
repeated to build the scaffold layer-
by-layer.
Stereolithography (SLA): an
additive manufacturing technology
that can be used for bioprinting in
which light is used to cure a
photosensitive resin. Through
different irradiation approaches the
various stereolithographic systems
use a layer-by-layer approach: the
energy delivered by the light is
sufficient to solidify a particular
thickness of the exposed resin and
join this layer with the previous one.
Tissue liquidity: the notion,
introduced by Malcolm Steinberg,
that tissues or multicellular
aggregates composed of motile and
adhesive cells have properties
Figure 1. (A) The contour lines represent the resolution/time for manufacturing (RTM) ratio, a figure that ranks the
biofabrication technologies according to their efficiency, taking into account resolution (x axis) and fabrication throughput (y
axis). A larger ratio represents a more efficient process. (B) An illustration defining the colors used in panel (A).
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analogous to liquids, evidenced by
the fact that irregular tissue
fragments spontaneously round up
into spheroids, and two fragments
composed of different cell types
mutually envelope each other. Such
tissues can be quantified in terms of
apparent tissue surface tension.
Two-photon polymerization (2PP):
a laser-based technique that uses a
near-infrared ultrashort-pulsed laser
to excite in a precise way and to
confine space molecules
(photoinitiators) to a two-photon
state, triggering the polymerization of
monomers in solution. This was the
first technique that allowed the
manufacturing of true 3D nano/
micro-structures without supports.
(i) Laser-based technologies (ii) 3D prinng (3DP)
(iii) Fused deposion modeling
(vi) Soluon or melt electrospining
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projection system instead of a laser source (known as digital light processing, DLPTM) [18,19].
Some of these also comprise hydrogel formulations, which would then allow the incorporation
of cells into the biofabrication process. Despite enhanced resolution (20–40 mm) with SLA,
the biocompatibility of these photopolymers and of the photoinitiators used for their cross-
linking remains to be fully validated. Incorporation of any biological material, including cells,
depends on their sensitivity to the light source used [20]. In addition, this method is limited to a
cell type that could be incorporated into a hydrogel. Using data in the literature, an RTM ratio of
about 0.5  103 m2/minute can be estimated for SLA, which places this method among the
more efficient techniques. In case of DLP, the RTM ratio can be increased to 2  103 m2/
minute by parallelization of the light beam. An improvement of SLA with respect to spatial
resolution is two-photon polymerization (2PP), where a spatially and temporally confined laser
beam polymerizes a photosensitive resin [21,22]. The resolution of this technology can reach
the sub-micron scale. Although new photocurable biomaterials with satisfactory biocompati-
bility are being developed, and the speed of this fabrication process has improved, further
progress in both materials development and fabrication rate is needed. The RTM ratio is
0.05  103 m2/minute, which means that 2PP has a very high resolution despite taking a long
time to manufacture large structures.
Fused Deposition Modeling
FDM has been extensively used to fabricate custom-made scaffolds and to modulate their
mechanical properties for tissue engineering applications, with encouraging results [23–25]. In
FDM, molten thermoplastic polymers are extruded into filaments. These filaments are depos-
ited to form a layer, and a 3D scaffold is built layer-by-layer. The entire process is controlled by a
CAD design. Several biocompatible thermoplastics have been developed and processed with
this technique. However, the majority of published work to date has used polycaprolactone as
the polymer of choice because of its relatively low melting temperature and its commercial
availability in medical grades. Many other extrusion-based tools inspired by FDM have been
developed to fabricate 3D scaffolds. These also comprise multi-dispensing systems, such as
3D fiber deposition (3DF) and bioextrusion, that allow the deposition of different materials and at
the same time produce constructs with locally differing physicochemical properties [4,23,26].
The main difference between FDM on the one hand, and 3DF and bioextrusion on the other, is
that in 3DF and bioextrusion the biomaterials are loaded into a cartridge as pellets or particles
instead of being extruded in a filament form. This approach has the advantage of expanding the
palette of biomaterials that can be used compared to FDM. An associated disadvantage of 3DF
and bioextrusion is higher susceptibility to thermal degradation owing to the long residence
times of the raw material at high temperatures. Although FDM, 3DF, and bioextrusion techni-
ques have considerably improved the quality of tissue engineered constructs with respect to
their functional performance [25,27–29], the high temperatures involved during the fabrication
of molten polymers may limit the direct incorporation of biological factors by this technique. A
solution could be envisaged if not only metallic [30] or ceramic pastes [31] are employed, but
also polymeric pastes that can be processed at room temperature. Alternatively, surface
modification techniques could be used to functionalize the fibers and allow grafting of bioactive
agents at specific sites [32]. In addition, hydrogels that encapsulate biological components
could be deposited together with thermoplastic materials, thereby circumventing the limitations
[33,34] imposed by the high temperatures. FDM, 3DF, and bioextrusion have the highest RTM
Figure 2. Commonly Used Technologies in Biofabrication with a Major and Active Role of Biomaterials in the
Printing Process. (i) Light-based technologies (selective laser sintering, stereolithography, two-photon polymerization),
(ii) 3D printing, (iii) fused deposition modeling, (iv) ink-jet printing, (v) 3D plotting, and (vi) solution and melt electrospinning.
Adapted, with permission, from [118–120].
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ratio of most of all methods, around 1  103 m2/minute. Because the post-processing phase
is practically nonexistent, there is a limited need for intervening layers or binders and solvents to
remove excess material, as with most other techniques.
Pressure-assisted microsyringe deposition (PAM)/wet-spun automated extrusion
systems have been developed to solve the disadvantages associated with high temperatures
in FDM, at the same time achieving scaffolds with a higher fiber resolution (80 mm for FDM vs
10 mm for PAM) [35,36]. PAM is part of the PAM2 system in which several working modules can
be mounted in parallel on a robotic micropositioner to allow simultaneous processing of
synthetic and natural polymer solutions as well as living cell suspensions [36,37]. The main
drawback of wet-spun extrusion-based technologies is the low vertical dimension (when high
resolution is sought), resulting in a medium RTM ratio of 0.5  103 m2/minute. This implies
that thick constructs take more time to be fabricated than with other extrusion technologies.
Recent progress by Lewis and colleagues might, however, solve such limitations by fabricating
arrays of nozzles that can deposit multiple filaments at the same time [38].
The major limitation of most scaffold fabrication processes reported in the literature is that each
technique is applicable only in particular conditions (e.g., rheology, pressure, temperature,
voltage) that restrict the choice of materials. Hydrogels composed of natural polymers (e.g.,
collagen, gelatin, hyaluronic acid), either in combination with additional biological factors or
used alone, are intrinsically biocompatible and biodegradable, and possess biological cues
[39]. However, these natural-polymer hydrogels are difficult to process with the techniques
discussed so far. As an alternative, scaffolds made of natural biomaterials can be produced by
indirect fabrication techniques (e.g., casting a biomaterial into a sacrificial mould formed by
additive manufacturing processes). Indirect methods to produce additive manufactured scaf-
folds have emerged in several different approaches, with promising results [40]. The develop-
ment of an alkali-soluble photopolymer allowed the use of indirect additive manufacturing
with hydrogels [41]. In particular, gelatin and collagen scaffolds could be produced by applying
indirect SLA manufactured moulds with high resolution and a minimum pore or strut size on the
scale of several tens of micrometers [42,43]. Indirect methods could be also combined with
conventional techniques, such as salt leaching and phase inversion, to fabricate dual-pore
scaffolds [44,45]. Some drawbacks still exist with indirect approaches, including the poor
resolution of the additive manufacturing techniques, the casting procedure, and the extraction
methods. For these reasons the RTM ratio is 0.03  103 m2/minute.
Bioplotting and Ink-Jet Bioprinting
Whereas all of the above-mentioned methods have demonstrated different degrees of success
in fabricating 3D scaffolds to accommodate cells that can develop into tissues or proto-tissue
structures, most are incapable of simultaneously depositing biomaterials and cells. Therefore,
cells need to be separately seeded into the scaffolds produced by these techniques. This limits
the flexibility to mimic cell distributions in native tissues, particularly when strategies for the
regeneration of multiple tissue interfaces or organs are to be developed. Three main sets of
technologies have demonstrated the ability to incorporate cells during the process of additive
manufacturing into a biomaterial carrier: 3D plotting (also known as bioplotting and extrusion
bioprinting), ink-jet bioprinting, and valve-jet bioprinting. In bioplotting, the cells are typically
encapsulated into a hydrogel carrier biomaterial and extruded by the application of pressure,
similarly to wet-spun extrusion based technologies [46–48]. This technique allows the deposi-
tion of different cell types in different hydrogel formulations, but is still limited in terms of speed of
production and fabrication of constructs with a complex shape, mostly because of the lack of
optimal hydrogel carriers (also called bioinks). The technique also has some limitations if a
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stable structure is to be formed. For example, it may be necessary to use a plotting bath
containing a fluid of matching density and viscosity to the extruded material to prevent sagging
or deformation of the construct immediately after extrusion, or alternatively to use a hydrogel
with sufficient viscosity to self-sustain its own weight after processing. An additional approach
that has emerged is the extrusion of material into 3D space of another material, in contrast to
building a structure from a surface [49–51]. This has been most commonly performed with
hydrogels (e.g., continuous or colloidal suspensions) where the material displaces as another
material is extruded into it, and has been used to print suspended objects or open-channel
structures with the use of sacrificial materials.
In ink-jet bioprinting, cells encapsulated into hydrogel carriers are dispensed in droplet fashion.
By ink-jet bioprinting it is possible to exquisitely control the number of cells per deposited
droplet, thus resulting in a finer control over cell distribution in the fabricated constructs [52,53].
The development of optimal hydrogels as bioinks for both bioplotting and ink-jet bioprinting
remains a challenge, and the fluid requirements for both methods are very different in terms of
fluid viscosity and surface tension [54]. The RTM ratio is 0.5  103 m2/minute for bioplotting
as a consequence of rapid scaffold production but low resolution, and 0.1  103 m2/minute
for ink-jet bioprinting due to high resolution but also high fabrication time per unit volume. In
both technologies the presence of living cells in the bioink limits the RTM ratio: higher extrusion
flow and smaller nozzles can induce damage due to shear stress on cell membranes [46–53].
Similar to the ink-jet technique, valve-jet bioprinting is a non-contact, droplet-based method
where cells are printed with or without hydrogel carriers [55]. The actuation mechanism for the
valve-jet is based on pneumatic pressure, and the ejection of droplets is controlled by solenoid
microvalves instead of by piezo- or thermal actuators as in ink-jet printing [56]. Currently, the
printing resolution (e.g., nanoliter droplet) and throughput (e.g., 1–1000 Hz) of valve-jet bio-
printing lie between bioplotting and ink-jet bioprinting, as does the printable fluid viscosity range
(up to 100 Pa.s). Because the technology is not limited by the nozzle size (as with ink-jet
printing), shear stress can be minimized and therefore the technology is amenable to print
delicate human pluripotent stem cells [57]. The RTM ratio is therefore 0.3  103 m2/minute
for valve-jet bioprinting.
Electrospinning
A further promising technique for scaffold fabrication is electrospinning. This technique pro-
duces fiber meshes with physical features mimicking those of the native extracellular matrix
(ECM). The fiber meshes are created by passing a biomaterial solution through a high-voltage
electric field near the deposition nozzle. At a defined voltage threshold, which is specific for a
defined biomaterial solution, the surface tension of the biomaterial solution is overcome by the
applied electric field, resulting in the formation of an electrohydrodynamic Taylor cone from
which fibers are spun and collected on a grounded target plate [58,59]. Despite being a
relatively old technology, originally developed for textile fiber production, this technique is now
widely used by the tissue engineering and regenerative medicine community because of the
wide range of materials available for the technique and the methods of fiber collection that allow
an expansive spectrum of structures and shapes to be fabricated [60,61]. An important recent
development in the field of electrospinning is the possibility to control the deposition of fibers at
the scale of a single fiber. This has been achieved by the so-called near-field electrospinning
technique for biomaterials in solution and by melt electrospinning writing for molten polymers
[62]. Together they constitute a method of electrohydrodynamic writing in which predictable
fiber paths are used to direct-write small-diameter fibers onto a translating collector. This new
electrospinning modality can potentially be used to create scaffold structures that can better
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mimic the native ECM not only by the physical dimensions of the constituent fibers but also in
terms of structural organization. Although cells have been shown to maintain their viability
after electrospinning [63,64], reports describing the possibility of electrospinning cell-laden
hydrogels are still limited [65,66]. The RTM ratio of this technique is currently around
0.1  103 m2/minute.
In addition to the techniques listed so far, several alternative biofabrication strategies that use
biomaterials only to provide structural integrity have been developed (Figure 3). The first
examples of these strategies were provided by the work of Forgacs and coworkers who
dispensed cell spheroids and cylinders into a hydrogel bed using special-purpose extrusion
bioprinters [67–69]. The hydrogel is used as a support, while a tissue-like structure forms by
exploiting the biophysical principles of tissue liquidity that governs the fusion of adjacent cell
aggregates. In this manner, branched vascular networks [67,70], nerve grafts [68,71], and
other tissue modules [69] have been successfully fabricated. Additional applications of this
technology resulted in commercial products in the form of architecturally and functionally
correct human tissue constructs for drug toxicology essays [72]. The principal limitations of this
approach are (i) the relatively slow fusion of the cell aggregates, which takes typically at least
24–48 h depending on the cells used, and may lead to a somewhat inhomogeneous construct;
(ii) low spatial resolution owing to the use of micropipettes of relatively large diameter (300 or
500 mm) for the preparation and deposition of gels and cells; and (iii) the limited diffusion of
nutrients when large constructs are fabricated. Owing to these limitations and to the low
resolution of this method, its RTM ratio is less than 0.001  103 m2/minute.
(A)
(D)
(B) (C)
(F)(E)
Temperature-responsive
coang
Figure 3. Example of Biofabrication Strategies that use Biomaterials To Provide Only Structural Integrity. (A) An extrusion bioprinter is used to deposit cell
aggregates as spheroids and/or cylinders. (B) Deposition strategy for fabricating a straight or (C) branched hollow shape. (D) Representation of cells culture on
thermoresponsive culture plates, and (E) cell-sheet stacking as steps for (F) obtaining a complex structure in a cell-sheet biofabrication method. Adapted, with
permission, from [121] and [81].
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A similar technology was developed by Nakayama and coworkers who used an ingenious
skewering system [73,74] wherein the cell spheroids are placed on fine metallic needles (i.e.,
skewers), geometrically positioned as to be consistent with the shape of the desired organ
structure (e.g., tubular construct; Figure 4). The novelty in this technology is that the needles
prevent the otherwise unavoidable shrinking of the construct upon fusion of the spheroids (at
least in one direction). Others have used a tangram-based concept in which different cellular
shapes were left to fuse with each other and self-assemble into a macroscopic tissue construct
[75–77]. Achieving fully vascularized large constructs with these tissue liquidity-based strate-
gies is still an open challenge. Owing to the long aggregation time of the cell aggregates, the
RTM ratio is slow, less than 0.001  103 m2/minute.
Another approach developed originally by Chrisey and colleagues [78], later further adopted by
Guillemot and colleagues [79], is based on laser-assisted bioprinting (LAB). This technique
has also been known as laser-induced forward transfer (LIFT) and matrix-assisted pulsed laser
evaporation (MAPLE). The deposition system is composed of three components: (i) a pulsed
laser source, (ii) a target from which a biological material is printed, and (iii) a receiving substrate
that collects the printed material. The target is made of a thin absorbing layer of metal (such as
gold or titanium) coated onto a laser-transparent support (e.g., glass or a transparent polymer
film). Organic materials (molecules or cells) are prepared in a liquid solution (e.g., culture media
or a hydrogel precursor) and are deposited at the surface of the metal film. The laser pulse
induces vaporization of the metal-absorbing layer, resulting in the production of a jet of liquid
solution which is deposited onto the substrate [80]. The resolution of this system depends on
parameters such as the thickness of the bioink layer coated onto the target, the surface tension
and viscosity of the bioink, the wettability of the substrate, the laser fluence, and the air gap
between the target and the substrate. LAB has a fairly low RTM ratio of around 0.04  103 m2/
minute owing high resolution and long fabrication time, which implies that thick constructs need
more time for manufacture compared to the other techniques described before, and some-
times the production time of large size structures is not compatible with cell processing times.
A different approach for the biofabrication of tissues and organs consists of bottom-up
approaches (Figure 3D–F) in which micro and nano modules are first engineered and used
as building blocks to fabricate the targeted tissues. One of the most successful bottom-up
approaches is represented by the cell-sheet engineering method developed by Okano and
colleagues, where cells are cultured until they reach confluence on thermoresponsive culture
(A) (B) (C)
Figure 4. Biofabrication Strategy Based on Skewering of Tissue Spheroids. (A) Custom-made device for automatic skewering. (B) Stacking strategy for
obtaining a hollow shape. (C) Vascular graft generated from mesenchymal stem cells using the skewering approach. Adapted, with permission, from [74].
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plates, which can easily release the formed cell layers by switching the temperature from 37C
to room temperature [81]. Larger constructs comprising multiple layers placed together in a
conventional layer-by-layer method have been fabricated and successfully brought to the clinic
[82]. With a similar approach, L’Hereux and coworkers developed and brought to the clinic a
layer-by-layer approach for fabricating vascular biological grafts from cell sheets [83].
Another classic example is the micro-masonry concept pioneered by the laboratories of
Khademhosseini and Demirci, among others, where micro-units of cell laden hydrogels are
used as regenerative building blocks [84–86]. The modularity of this approach is limitless.
Hydrogels of different compositions that embed different cells can be mixed. Recently,
functionalization with DNA segments was also demonstrated, and this resulted in a more
biological dynamic recognition of different building blocks during in vitro assembly [87].
Furthermore, such blocks can be also precisely positioned using microrobots [88].
Despite the great flexibility promised by these methods, further studies will be necessary to
effectively demonstrate the fabrication of clinically relevant large vascularized constructs to
compensate for the known nutrient-diffusion limitations of most hydrogel systems. Similar
approaches have been also developed by combining solid micro- and nanoparticles with cells,
thus offering the advantage of engineering the shape and size of such objects, which can
possibly offer further stimuli to direct cell differentiation, particularly when stem cells are used
[89,90]. Their use in combination with cells offers the possibility to impinge on cellular conden-
sation, which results in tissue shrinking, thus offering the opportunity to maintain the dimension-
ality of large tissue constructs. For bottom-up approaches the RTM ratio is lower than
0.001  103 m2/minute; these low values are principally due to the long fabrication time
for the production of cell sheets or microunits and the time required for the fusion of the different
cell sheets or microunits.
Microfluidic technology has also boomed in the recent years to create tissue-on-chip
platforms that can recapitulate key functions of targeted tissues and organs. These platforms
are typically used in association with a biomaterial formulation, namely hydrogel networks, to
culture cells in 3D and study mechanisms behind pathological events and possible treatments.
Examples comprise studies on cancer metastasis, lung, liver, intestine, and vessels, among
others [91–95]. Further development of these platforms will comprise the integration of sensors
to monitor in real-time cell and tissue functionality, as well as other biomaterial formulations, to
better replicate native ECM of the targeted tissues to be studied. A further advancement in
these bio-assembly biofabrication strategies has been reported by Takeuchi and coworkers,
where meter-long cellular fibers have been created through microfluidic technology and proved
to be efficacious in the regeneration of several tissues in preclinical animal models [96]. Cellular
fibers are created by encapsulating cell-containing ECM proteins in a pre-gel state in mechani-
cally stable Ca alginate hydrogel carrier in a coaxial manner, and by dissolving the carrier
hydrogel upon the gelation of the cell-containing ECM. These fibers have also been weaved,
thus creating cellular fiber scaffolds [97].
Implications for an Integral Terminology and Future Perspectives
In this review we have made a first attempt to define a metric that can compare the fabrication
efficiency of the main current biofabrication technologies and that is usable with new methods
as they are being developed. If used in the common range of biofabrication applications (i.e.,
minimum feature size d less than 500 mm), although dimensionally complex, the RTM ratio will
objectively classify the continuous optimization and advances in current biofabrication tech-
nologies (Box 1). A practical example is the recent development of a new SLA technology by the
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group of DeSimone, called continuous liquid interface production (CLIP), which allows creating
3D objects 100-fold faster than conventional SLA [98]. Whether this technology could be
translated to biomaterials or cell-laden hydrogels remains to be demonstrated, but an estimate
of its RTM ratio is 5  103 m2/minute. In addition to constraints associated with the physical
principles behind each technology and the chemistry of currently available biomaterials, the
RTM ratio can be increased by parallelization of printing heads: light-based technologies better
than others can exploit this route, and projection SLA (known as digital light processing, DLPTM)
is a clear and extreme example in this direction [19]. Another technological challenge is the
fabrication of complex anatomically shaped constructs. Whereas current bioprinting technol-
ogies can already achieve non-intricate structures, the recent development of new colloidal inks
and optimized bathing stages in which the bioprinting process takes place could offer new
solutions to further increase the degree of complexity in mimicking native organs [50,51]. In
particular, the use of high buoyant density liquids [99], sacrificial fugitive materials [100], or
granular gels [50,101] as media into which bioinks are deposited is becoming a new exciting
Box 1. Factors Influencing the RTM Ratio
The RTM ratio and the ‘d-P’ parameter space can quantitatively and visually classify the various biofabrication
technologies, respectively, and they can also indicate possible research directions to improve the efficiency of a
specific technology. The RTM ratio is given by the printing rate and the minimum feature size achievable with a specific
technology. This minimum feature size is determined by the physics beyond the fabrication process, strictly depending
on the involved physical principles (e.g., photopolymerization, heat diffusion, and so on) and on the materials (polymers,
ceramics, metals) and their physical state (solid, powder, liquid, gel, slurry). The spatial resolution can be improved by
working on the development of new materials and processes rather than on technological optimization.
The printing rate can depend on the complexity of the printed shape, both in terms of geometry and multi-material
composition (Table I). Biofabrication technologies based on a ‘vector scanning’ strategy for tracing the trajectories that
lead to construct fabrication result in longer printing time in case of complex geometries, compared to those based on
‘raster scanning’ or ‘projection’ strategies. Multimaterial composition can also increase the fabrication time if different
materials cannot be processed at the same time.
Table I. Factors Influencing the Printing Time
Technique Geometrical complexity Multimaterial fabrication
Vector
Selective laser sintering " Not allowed
Laser ablation " Not allowed
Stereolithography " Not allowed
Two-photon polymerization " Not allowed
Fused deposition modeling " "
PAM2 " "
Bioplotting " "
LAB " "
Raster
3D printing = Not allowed
Ink-jet bioprinting = =
Valve-jet bioprinting " "
Projection
Digital light processing = Not allowed
Symbols: ", increase; =, no substantial change.
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avenue to fabricate larger and more complex constructs. For a more in-depth review on
supporting temporary sacrificial materials we refer elsewhere [102].
With the development of new bioprinting processes, it is nowadays possible to manufacture
tissues with different levels of complexity (Figure 5A–C). This is achieved by heterogeneous
combinations of different cells and bioinks. The degree of complexity needed to mimic and
eventually replace a tissue and ultimately an organ has started to be considered for constructs
tested in vitro [103,104] and in vivo [105]. With initial minor functional outcomes, further
understanding of the level of mimicry and complexity necessary to achieve optimal functional
tissue or organ replacement is expected as the field matures.
In the perspective of commercial-scale production, other standards of quality should be taken
into consideration, such as: (i) accuracy, or how closely the output of a manufacturing output
conforms to a tolerance within a specified dimensional range, and (ii) repeatability, which
captures the ability of the equipment to produce consistent output, time after time. These
parameters are necessary to reduce the extrinsic variability of the advanced tissue models
owing to microenvironmental properties, limiting the intrinsic variability related to the cells
themselves [40]. Quality control requires a consensus on metrology: limiting the discussion to
geometrical consideration, a least-squares fit of a point cloud representing the scaffold (e.g.,
from a mCT scan) to its CAD model, can give a measure of the fabrication error [106,107].
Interestingly, additive manufacturing processes allow for in-process inspection of the internal
structure of a component. Furthermore, the accuracy over time (long-term stability) is directly
related to the off-the-shelf availability and, in a more prosaic way, to shipping and storing
methods [108].
Finally, new hydrogels need to be developed that are able to maintain at the same time cell
viability and activity, as well as the physical shape of the final printed construct [109–111]. The
dynamic behavior of native ECM is an appealing feature that could be incorporated into new
bioinks in future biofabrication strategies. In this respect, what is nowadays called 4D printing
could allow such integration where the use of stimulus-responsive materials allows a spatio-
temporal change in a 3D object [112,113]. Whether we are really witnessing 4D printing, a
process that should be defined as a programmed temporal shape change occurring during the
3D manufacturing itself, or not, is still to be clarified in the field. We advocate for cautious use of
the term 4D printing because all reports so far published in literature show 3D objects that can
change shape after the 3D manufacturing process. Nonetheless, these time-morphing 3D
objects are certainly an exciting new development of conventional additive manufacturing,
which would be thrilling to see to be translated into novel biofabrication strategies.
Concluding Remarks and Recommended Guidelines
As the biofabrication community expands and the applications of this technology grow, it is
important to establish a set of definitions and terminology that will help to normalize discussion
and reports of developments in the field (see Outstanding Questions). Some attempts have
been already made in the case of 3D scaffolds; for example, the National Institute for Standards
and Technology of the United States of America is adopting 3D scaffolds fabricated by additive
manufacturing technologies as standards for 3D cell culture [114]. Further standards could be
Figure 5. Examples of Complex Heterogeneous Bioprinted Structures. (A) Bioprinting of shear-thinning supramolecular hydrogels into self-healing support
gels allowing continuous manufacturing in 3D space while patterning multiple inks and cells. (B) Example of 4D printing for stimulus-responsive materials that allow
spatiotemporal changes (e.g., by swelling). (C) Example of hierarchically branched tubular networks generated by granular gel printing. Adapted, with permission, from
[49,50,121]. Scale bars in A and B are 200 mm and 2,5 mm, respectively.
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sought into the realm of advanced manufacturing, as recently pointed out by Hutmacher and
coworkers, who coined the term ‘additive biomanufacturing’ when standard norms such as
ASTM or ISO are applied to the biofabrication field [115]. In this context it is important to note
that biomanufacturing means the use of living organisms to manufacture a product. In a recent
review the term has been defined more precisely as ‘a type of manufacturing that utilizes
biological systems (e.g., living microorganisms, resting cells, plants, animals, tissues, enzymes,
or in vitro synthetic (enzymatic) systems) to produce commercially important value-added
biomolecules for use in the agricultural, food, energy, material, and pharmaceutical industries’
[116]. Therefore, it is not clear what the combined term ‘additive biomanufacturing’ actually
means. This should be defined before taking into account its use as part of an industrial norm. In
the case that the biological systems considered by Zhang and colleagues are used as part of a
fabrication approach, we wish to stress that, according to the most recent definition of
biofabrication [1], ‘additive biomanufacturing’ is a subfield of biofabrication.
We propose here a clarification and classification of the different biofabrication terminologies in
current use. In this respect, we recommend that the term 3D printing no longer be used as a
general term for all additive manufacturing technologies applied to biofabrication strategies
because 3D printing represents only one such technology, as previously described. Instead, we
recommend using the name of the specific technology used to create a biofabricated con-
struct, as outlined in this article. When referring to more general biofabrication strategies in
tissue engineering and regenerative medicine, we recommend using the two general terms
bioprinting or bioassembly. As we previously defined [1], bioprinting refers to the use of
computer-aided transfer processes for patterning and assembling living and non-living materi-
als with a prescribed 2D or 3D organization to produce bio-engineered structures; bio-
assembly refers to the fabrication of hierarchical constructs with a prescribed 2D or 3D
organization through automated assembly of pre-formed cell-containing fabrication units
generated via cell-driven self-organization or through preparation of hybrid cell–material build-
ing blocks. We advise members of the community to adopt this terminology approach in their
new studies and that the media will report advances in the field with the correct language,
instead of broadly using only the term 3D printing.
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